Epithelial innate immune response to Acinetobacter baumannii challenge

Area of Science:

• Microbiology
• Immunology
• Cell Biology

Background:

• Acinetobacter baumannii is a significant healthcare-associated pathogen.
• The innate immune response to A. baumannii is not fully understood.
• Human beta-defensins (hBDs) are antimicrobial peptides (AMPs) involved in innate immunity.

Purpose of the Study:

• To investigate the induction of hBD-2 and hBD-3 by A. baumannii in oral and skin epithelial cells.
• To determine the susceptibility of A. baumannii to hBD-2 and hBD-3.
• To elucidate the signaling pathways involved in hBD induction.

Main Methods:

• Primary oral and skin epithelial cells were treated with A. baumannii.
• Gene expression of hBD-2 and hBD-3 was quantified.
• Bacterial killing assays were performed using hBD-2 and hBD-3.
• Involvement of epidermal growth factor receptor (EGFR) signaling, mitogen-activated protein kinase (MAPK), ADAM17, ADAM10, and Duox1 was assessed.

Main Results:

• A. baumannii induced hBD-3 transcripts more than hBD-2 transcripts in both cell types.
• A. baumannii was susceptible to killing by hBD-2 and hBD-3 at submicromolar concentrations.
• hBD-3 induction was dependent on EGFR signaling.
• MAPK inhibition reduced hBD-2 and hBD-3 expression.
• ADAM17 was critical for hBD-3 induction, while ADAM10 and Duox1 were not required.

Conclusions:

• Induction of hBDs is a key component of the innate immune response to A. baumannii.
• hBD-3 plays a significant role in controlling A. baumannii infection.
• EGFR and ADAM17 signaling pathways are crucial for hBD-3 induction.
• Understanding these interactions may reveal vulnerabilities to A. baumannii infection.